SCHEMBL873604

SCHEMBL873604

O=CCNC=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6741999 0.77
SCHEMBL6993079 0.77 ADH1B (0.41)
SCHEMBL13465149 0.72
SCHEMBL9600 0.72
SCHEMBL18360227 0.72
SCHEMBL6013871 0.70
Hydrochloric Acid SCHEMBL28187531 0.69
SCHEMBL4791736 0.67
SCHEMBL10496358 0.67
SCHEMBL21320264 0.67

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 177 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110420573-A A kind of preparation method of lithium ion battery electrocondution slurry HUARUI MOSHI DANYANG CO LTD 2019-11-08 CN claimed
EP-2643000-A2 THERAPEUTIC PIPERAZINES Dart Neuroscience (Cayman) Ltd (KY) 2013-10-02 EP claimed
WO-2012040258-A2 THERAPEUTIC PIPERAZINES HELICON THERAPEUTICS, INC. (US) 2012-03-29 WO claimed
US-20110065691-A1 THERAPEUTIC PIPERAZINES DART NEUROSCIENCE (CAYMAN) LTD. (KY) 2011-03-17 US claimed
US-20100113770-A1 O-SUBSTITUTED HYDROXYARYL DERIVATIVES INSTITUTE OF MEDICINAL MOLECULAR DESIGN, INC. (JP) 2010-05-06 US claimed
US-20070004765-A1 New compounds BIOVITRUM AB (SE) 2007-01-04 US claimed
WO-2006122931-A1 BETA-CARBOLINE DERIVATIVES AND THERI USE AS GHSR MODULATORS BIOVITRUM AB (PUBL) (SE) 2006-11-23 WO claimed
US-20050288316-A1 Beta-carbolines as growth hormone secretagogue receptor (GHSR) antagonists BIOVITRUM AB (SE) 2005-12-29 US claimed
WO-2005048916-A2 TETRAHYDROSPIRO-BETA-CARBOLINE-1,3 '-PYRROLIDINE DERIVATIVES AND THEIR USE IN GHSR-RELATED DISORDERS BIOVITRUM AB (SE) 2005-06-02 WO claimed
US-20040063701-A1 Piperidine derivatives and anti-platelet agents containing the same AJINOMOTO CO., INC (JP) 2004-04-01 US claimed
EP-0976735-B1 PROCESS FOR PRODUCING PIPERIDINECARBOXYLIC ACID AMIDES AJINOMOTO KK (JP) 2003-10-29 EP claimed
US-20020147195-A1 Piperidine derivatives and anti-platelet agents containing the same AJINOMOTO CO., INC. (JP) 2002-10-10 US claimed
US-20020019533-A1 PIPERIDINE DERIVATIVES AND ANTI-PLATELET AGENTS CONTAINING THE SAME MAKINO SHINGO (JP) 2002-02-14 US claimed
EP-0682015-B1 Piperidine derivates and anti-platelet agents containing the same AJINOMOTO KK (JP) 2001-08-22 EP claimed
EP-1103544-A2 Piperidine derivatives and antiplatelet agents containing the same Ajinomoto Co., Inc. (JP) 2001-05-30 EP claimed
US-6207834-B1 REACTING 2-OXAZOLINE COMPOUND WITH A PIPERIDINE DERIVATIVE AJINOMOTO CO., INC. (JP) 2001-03-27 US claimed
EP-0976735-A1 PROCESS FOR PRODUCING PIPERIDINECARBOXYLIC ACID AMIDES Ajinomoto Co., Inc. (JP) 2000-02-02 EP claimed
EP-0474767-B1 DOPAMINE AGONISTS ABBOTT LAB (US) 1996-02-21 EP claimed
EP-0682015-A1 Piperidine derivates and anti-platelet agents containing the same Ajinomoto Co., Inc. (JP) 1995-11-15 EP claimed
US-4401658-A VACCINE ADJUVANTS, IMMUNOSTIMULANTS RHONE-POULENC SANTE (FR) 1983-08-30 US claimed